Email : [email protected]
Tel : +44 (0)1666 519900
Prof John Manners-Bell is Chief Executive of Ti, Honorary Visiting Professor at the London Metropolitan University’s Guildhall Faculty of Business and Law and an adviser to the World Economic Forum. He has over 25 years’ experience working in and analysing the global logistics sector. John started his working life as an operations manager of a logistics company based in the UK. Prior to establishing Ti in 2002, he worked as an analyst in consultancies specialising in international trade, transport and logistics. He also spent a number of years as a manager of UPS, in a strategic marketing and communications role. John holds an MSc in Transport Planning and Management from University of Westminster and is an Associate of King’s College London where he studied Classics and Theology. He is a Fellow of the UK Chartered Institute of Logistics and Transport and former Chair of the Supply Chain and Logistics Global Advisory Council of the World Economic Forum. He has also advised the European Commission Directorate-General for Energy and Transport. He has written three books on the industry – ‘Global Logistics Strategies: Delivering the Goods’, ‘Supply Chain Risk: Understanding Emerging Threats to Global Supply Chains’ and ‘Logistics and Supply Chains in Emerging Markets’. His second book, ‘Supply Chain Risk’ won the Mention Speciale ACA-Bruel Prize for supply chain literature in 2014.
Contact John: [email protected]
The world's largest collection of global supply chain intelligence
Julia Swales interviewed Alan McKinnon, Professor of Logistics at the Kuehne Logistics University in Hamburg, about decarbonization and climate proofing and the logistics challenges involved.
92% of the world economy is now covered by net zero pledges, but the carbon sequestration side of this is often overlooked. Reaching net zero is not just a matter of mitigating and reducing emissions, it’s about removing greenhouse gases already in the atmosphere. Of course, the more we underperform in mitigation, the more dependent we will be on sequestering greenhouse gases already in the atmosphere. That process is very logistics intensive, particularly if you look at the IPCC models and their projection for the amount of CO2 (8 billion tonnes) we’re going to have to capture, transport, and find underground places for permanent storage by the 2050s.
In an interview with Marcello Ferrari, VP Global Head of Customer Development, Healthcare Contract Logistics at Kuehne+Nagel, Julia Swales, Senior Editor at Ti asked him about the current state of the healthcare industry vertical. Marcello Ferrari talked about the macro perspective – market trends, the strategies they apply and how they respond to the dynamics …
In an interview with Poul Woodall, a senior manager in international shipping, he told Ti about the EU recently announcing that companies and shipowners will be able to blend sustainable fuels from a non-biological origin with fossil fuels, to reduce the average carbon content. This reduction is required by the FuelEU Maritime Initiative, which forms …
There can be economic, strategic or security imperatives behind attracting manufacturing jobs back from Asia (reshoring). However, in many other cases, the reasons are often nakedly political and the results disastrous – governments are very bad at backing ‘winners’ and often capricious with tax spend due to competing priorities.
Julia Swales talked to Alan Braithwaite, a Director of e-cargo bikes.com, and an advisory board member of The Foundation for Future Supply Chain, to find out what’s happening now, a year on from her last interview with CEO James FitzGerald. The first major change on this ‘journey’ is the transition to a second generation of …
In a webinar for LogiPharma, Jamie Pearce, VP and General Manager in Temp at Merck and Patrick Pichler, Director, Head of Global Distribution Quality, Merck Healthcare KGaA/EMD Serono, talked about how they are dramatically improving efficiency across their cold chain operations. Merck is responsible for the quality distribution and temperature monitoring of pharmaceuticals. In the …
At LogiChem in Rotterdam, on 14 March 2023, a question was put to three panellists: Justin Lanyon, Global Supply Chain Director, Arkema; Leo Kuetten, Logistics Leader EMEA, Dupon; Istvan Lencz, Global Director of Logistics at Henkel: “How can you collaborate with your logistics procurement team to give your chemical supply chain capabilities a competitive edge?” They were also asked, “Where does sustainability come into this? Is it even a consideration when choosing suppliers?” It’s clear that the chemical industry must integrate sustainability into its corporate strategy, but it needs better processes, technology and simplification of data gathering on scope 3. Procurement insight, transparency and collaboration with suppliers will deliver benefits and competitive advantage.
In a delegate survey conducted at LogiChem EU on 13 March 2023 in Rotterdam, the question was asked, “Do you have a supply chain visibility solution?” The responses were interesting – around 14% of companies have a solution fully implemented, 50% of companies are at the point of rolling out a solution, 17% are at …
There is a shift towards less mass textile production in China, due to a combination of higher costs, concerns about working conditions and chaotic supply chains. The shift was accelerated by continued supply chain disruption after the onset of the Covid-19 pandemic, which led to a jump in freight costs and shipping delays. This resulted in the textile and garment sector looking for alternative markets.
Clearly sustainability is going to need to become a really significant part of pharmaceutical companies’ business strategies if they are going to progress from where they are today to carbon neutral by 2030.
Pfizer is the largest global pharmaceutical company by revenue. In 2021, Pfizer produced revenues of €78,460.52m, a 51% increase on its 2020 revenue of €40,199.44m. Pfizer and German biotechnology company BioNTech SE collaborated to jointly develop a COVID-19 vaccine using BioNTech’s messenger RNA (mRNA) vaccine program. The Covid-19 vaccine was the first to be approved …
